Pharmacopsychiatry

Issue 04 · July 1986

Recommend Journal

Editorial
127
Delini-Stula, A.:
14th AGNP Meeting, Nürnberg 1985

Full Text PDF (73 kb)
Schizophrenia and Antipsychotic Drugs Introductory Papers
128
Heimann, H.:
Models of Experience and Behavior in Psychotic Disorders

Full Text PDF (411 kb)
134
Delini-Stula, A.:
Neuroanatomical, Neuropharmacological and Neurobiochemical Target Systems for Antipsychotic Activity of Neuroleptics

Full Text PDF (406 kb)
145
Langer, G.; Ackenheil, M.; Dixon, A. K.; Kurtz-May, G.; Möller, H. J.; Müller-Spahn, F.; Pietzcker, A.; Saletu, B.; Schönbeck, G.:
The Psychopharmacology and Neuroendocrinology of Neuroleptics: The State of the Art from a Clinical Perspective

Full Text PDF (326 kb)
149
Christensen, A. V.; Greil, W.; Haag, H.; Havemann, U.; Kehr, W.; Kuschinsky, K.; Porsolt, R. D.; Rüther, E.; Tegeler, J.:
Animal Models for Assessing Extrapyramidal-Motor Side-Effects of Neuroleptics

Full Text PDF (257 kb)
156
Möller, H. J.:
Methodological Problems of Long-term Studies in Psychopharmacology

Full Text PDF (426 kb)
161
Pietzcker, A.; Gaebel, W.; Köpcke, W.; Linden, M.; Müller, P.; Müller-Spahn, F.; Schüssler, G.; Tegeler, J.:
A German Multicenter Study on the Neuroleptic Long-term Therapy of Schizophrenic Patients

Full Text PDF (376 kb)
167
Greil, W.; Haag, M.; Huber, D.; Schmidt, St.:
Maintenance Treatment in Affective Disorders: Overview and Design of a Collaborative Study

Full Text PDF (192 kb)
172
Fuhr, P.; von Luckner, N.; Woggon, B.:
Can Pretreatment Data Predict Withdrawals in Clinical Trials of Psychotropic Drugs?

Full Text PDF (122 kb)
174
Woggon, B.; Biber, M.; Stassen, H. H.:
Clinical Trials of Antidepressants: Have the Patient Samples Changed During the Years?

Full Text PDF (133 kb)
176
Bender, W.; Haag, M.; Haag, H.; Greil, W.; Engel, R.:
Compliance in Psychiatry: Development of a Patient Questionnaire

Full Text PDF (120 kb)
178
Maier, W.; Philipp, M.; Schlegel, S.; Heuser, I.; Buller, R.; Frommberger, U.; Wetzel, H.; Wilhelmi, D.; Wittenborg, A.; Demuth, W.:
Operational Diagnoses for Schizophrenic and Schizoaffective Disorders

Full Text PDF (117 kb)
180
Philipp, M.; Maier, W.; Frommberger, U.; Wilhelmi, D.; Wetzel, H.; Schlegel, S.; Buller, R.; Heuser, I.; Demuth, W.; Wittenborg, A.:
Operational Diagnoses for Schizophrenic and Schizoaffective Disorders

Full Text PDF (121 kb)
182
Heuser, J.; Maier, W.:
Depression, Melancholia, and Memory Recognition:
A Signal Detection Analysis

Full Text PDF (142 kb)
184
Schlegel, S.; Kretzschmar, K.:
Computerized Tomographic Findings in Affective Disorder

Full Text PDF (141 kb)
186
Kohnen, R.; Krüger, H. P.:
Drug Effects on Human Social Behavior:
Changes in Talking Activities Induced by CGP 361/A, a Beta-blocking Agent

Full Text PDF (139 kb)
188
Gaebel, W.; Ulrich, G.:
Visuomotor Performance of Schizophrenic Patients and Normal Controls - I. Results of a Visual Fixation Task

Full Text PDF (141 kb)
190
Gaebel, W.; Ulrich, G.:
Visuomotor Performance of Schizophrenic Patients and Normal Controls - II. Results of a Visual Search Task

Full Text PDF (117 kb)
192
Giedke, H.:
Hibernation as a Model of Endogenous Depression

Full Text PDF (178 kb)
194
Filser, J. G.; Spira, F. J.; Gabel, A.; Beckmann, H.; Müller, W. E.:
Comparative Determination of 3-Methoxy-4-Hydroxyphenylglycol and its Conjugated Derivatives in the Urine of Depressed Patients and Healthy Controls

Full Text PDF (145 kb)
196
Bohl, J.; Störkel, St.; Schulze, E.; Tschank, G.; Haas, St.; Krausbeck, E.; Gather, W.; Katzman, K.; Brocks, D.:
Alzheimer's Disease: A Cerebral Amyloidosis
A Cooperative Study to Correlate Clinical, Biochemical and Pathologic-anatomical Findings

Full Text PDF (140 kb)
200
Ziegler, G.; Ludwig, L.; Fritz, G.:
Effect of the Specific Benzodiazepine Antagonist Ro 15-1788 on Sleep

Full Text PDF (154 kb)
202
Renfordt, E.; Ulrich, G.:
Relations among Psychopathology, Nonverbal Behavior (Speech Activity), and Neurophysiology (Topography of Alpha Power) under Antidepressive Drug Treatment

Full Text PDF (108 kb)
206
Dreher, A.; Baer-Degitz, M.; Köchert, R.; Nagel, L.; Salzer, W.-W.:
Clinical Study of the Correlation Between the Antipsychotic Operative Dose of Perphenazine and Fine Motor Extrapyramidal Inhibition in Haase's Handwriting Test

Full Text PDF (107 kb)
210
Klieser, E.; Felgenträger, H. J.:
Fluperlapine: A Therapeutic Alternative in Schizophrenic Psychoses

Full Text PDF (135 kb)
212
König, W.; Kunow, J.; Kniehl, R.; Reimer, F.:
Neuroleptics in the Treatment of Schizophrenia: Have there been Changes in the Dosage Regimen?

Full Text PDF (106 kb)
214
Gutzmann, H.; Gaebel, W.; Linden, M.:
One Year Follow-up of Schizophrenic Patients in Private Psychiatric Practice

Full Text PDF (123 kb)
216
Ruhland, M.; Fuchs, A. M.:
Lack of Antagonism by Ro 15-1788 on Timelotem (KC 7507) - a Benzodiazepine with Antipsychotic and Anxiolytic Properties

Full Text PDF (126 kb)
218
Ruhland, M.; Tulp, M.; Muesch, H. R.; Fuchs, A. M.:
Timelotem - an Antipsychotic Benzodiazepine Derivative

Full Text PDF (139 kb)
220
Ulrich, G.; Müller-Oerlinghausen, B.; Gaebel, W.:
Changes in the Topographical Distribution of Absolute Alpha-power in the Resting EEG of Schizophrenic In-patients under Neuroleptic Medication

Full Text PDF (125 kb)
222
Gaebel, W.; Ulrich, G.:
Topographical Distribution of Absolute Alpha-power in Schizophrenic Outpatients - On-drug Responders vs. Nonresponders

Full Text PDF (119 kb)
224
Wildenauer, D. B.; Bondy, B.; Welter, D.; Ackenheil, M.:
The Phospholipid Composition of Lymphocytes in Schizophrenic Patients: Effect of Treatment with Neuroleptics

Full Text PDF (114 kb)
228
Naber, D.; Albus, M.; Bürke, H.; Müller-Spahn, F.; Münch, U.; Reinertshofer, T.; Wissmann, J.; Ackenheil, M.:
Neuroleptic Withdrawal in Chronic Schizophrenia.
CT and Endocrine Variables are not Valid Predictors of Psychopathological Changes

Full Text PDF (165 kb)
230
Schreiber, W.; Kissling, W.; Möller, H. J.; Bäuml, J.; Gain, T.; Bottermann, P.:
TRH-Test and Psychiatric Disorders

Full Text PDF (132 kb)
232
Mühlbauer, H. D.; Müller-Oerlinghausen, B.:
Fenfluramine Stimulation of Morning Cortisol in Manic-depressive Patients and Lithium Prophylaxis: A Marker of (Auto-) Aggressiveness and Prophylactic Response?

Full Text PDF (71 kb)
233
Roncoroni, D.:
Prolactin as an Index of Neuroleptic Effects on the Neuroendocrine Regulatory Activity of the Hypotalamic Pituitary System

Full Text PDF (113 kb)
235
Laakmann, G.; Neuhauser, H.; Hinz, A.; Neulinger, E.; Wittmann, M.:
Stimulation of Growth Hormone, Prolactin, and Cortisol by GHRH and DMI in Depressed Patients

Full Text PDF (126 kb)
237
Laakmann, G.; Hinz, A.; Munz, T.; Schoen, H.-W.; Wittmann, M.; Zygan, K.:
Interactions of Alpha-2/Beta Receptors and DMI-lnduced GH, PRL and Cortisol Stimulation

Full Text PDF (131 kb)
239
Laakmann, G.; Hinz, A.; Neulinger, E.; Strauss, A.; Wittmann, M.:
DMI-Induced Growth Hormone Stimulation in Healthy Subjects and Depressed Patients

Full Text PDF (145 kb)
241
Mühlbauer, H. D.; Ziolko, H. U.:
Abnormalities of Anterior Pituitary Responsiveness to Hypothalamic Hormones in Bulimia

Full Text PDF (86 kb)
245
Delini-Stula, A.; Hunn, Ch.:
Effects of Imipramine and Brofaromine, a Selective and Reversible MAO-A Inhibitor, on Novelty-oriented Behaviour in Rats

Full Text PDF (136 kb)
247
Kapfhammer, H. P.; Hoff, P.; Golling, H.; Rüther, E.; Schmauss, M.:
Cimoxatone and Moclobemide, Two New MAO-lnhibitors, in the Treatment of Major Depressive Disorder

Full Text PDF (128 kb)
249
Hoff, P.; Golling, H.; Kapfhammer, H. P.; Lund, R.; Pakesch, G.; Rüther, E.; Schmauss, M.:
Cimoxaton and Moclobemid, Two New MAO-lnhibitors:
Influence on Sleep Parameters in Patients with Major Depressive Disorder

Full Text PDF (146 kb)
251
Schmauss, M.; Kapfhammer, H. P.; Meyr, P.; Hoff, P.:
Combined MAO-inhibitor and Tri-(Tetra) Cyclic Antidepressant Treatment in Therapy Resistant Depression

Full Text PDF (167 kb)
253
Wendt, G.; Binz, U.; Fischer, E.:
Long-term Treatment with Oxaprotiline in Patients with Endogenous Depression

Full Text PDF (120 kb)
255
Linden, M.; Schüssler, G.:
Compliance and Treatment Outcome of Antidepressant Therapy in Private Psychiatric Practice

Full Text PDF (155 kb)
257
Boll, E.; Tarighati, M. A.; Holsboer, F.:
Clinical Application of Antidepressant-Plasma Level Analysis with High Pressure Liquid Chromatography (HPCL)

Full Text PDF (132 kb)
259
Giedke, H.; Axmann, D.; Gaertner, H. J.; Rein, W.; Rötzer-Zimmer, F. T.:
Psychophysiological Predictors of Antidepressant Therapy Response?

Full Text PDF (171 kb)
262
Philipp, M.; Beck, V.; Scherhag, R.; Glocke, M.; Schmidt, R.:
Biological and Psychopathological Prediction of Response to Doxepine in Depressive Outpatients

Full Text PDF (134 kb)
264
Schmauss, M.; Laakmann, G.; Dieterle, D.:
Yohimbine in Combination with Tricyclic Antidepressants in the Treatment of Therapy-Resistant Depressed Patients

Full Text PDF (143 kb)
266
Schmauss, M.; Laakmann, G.; Dieterle, D.:
Influence of Nomifensine on Prolactin Secretion in Depressed Inpatients

Full Text PDF (156 kb)
268
Süss, St.; Boll, E.; Holsboer, F.:
Urinary Multisteroid Analysis Applying Glass-capillary Gas-chromatography - A New Technique to Assess Adrenocortical Activity in Depression

Full Text PDF (155 kb)
270
Ulrich, G.; Renfordt, E.; Frick, K.:
Electroencephalographic Dynamics of Vigilance and Drug-response in Endogenous Depression.
A Comparison of Patients Treated with Amitriptyline or Pirlindole

Full Text PDF (107 kb)
272
Ulrich, G.; Renfordt, E.; Frick, K.:
The Topographical Distribution of Alpha-activity in the Resting EEG of Endogenous-depressive In-patients with and without Clinical Response to Pharmacotherapy

Full Text PDF (111 kb)
276
Calker, D. van; Greil, W.:
Effects of Lithium Ions on the Metabolism of Phosphoinositides: Studies with Rat Pheochromocytoma Cells (PC-12 cells)

Full Text PDF (129 kb)
278
Haag, M.; Heidorn, A.; Haag, H.; Greil, W.:
Response to Stabilising Lithium Therapy and Sequence of Affective Polarity

Full Text PDF (144 kb)
280
Möller, H. J.; Kissling, W.; Tavan, S.; Winter, I.:
Is Carbamazepine Able to Increase the Antimanic Effect of Haloperidol?

Full Text PDF (143 kb)
282
Cabrera, J. F.; Mühlbauer, H. D.; Schley, J.; Stoll, K. D.; Müller-Oerlinghausen, B.:
Long-term randomized Clinical Trial on Oxcarbazepine vs Lithium in Bipolar and Schizoaffective Disorders: Preliminary Results.

Full Text PDF (118 kb)
284
Müller-Oerlinghausen, B.; Imiela, M.:
In-vitro and In-vivo Studies on the Pharmacokinetics and Clinical Efficacy of Lithium Aspartate as Compared to Conventional Lithium Preparations

Full Text PDF (122 kb)
286
Volk, J.; Müller-Oerlinghausen, B.:
Time Course of AMP-Documented Side-effects in Patients under Long-term Lithium Treatment

Full Text PDF (97 kb)
290
Wastl, R.; Grohmann, R.; Rüther, E.:
Frequency of Increased Serum Liver-enzyme Levels under Treatment with Neuroleptics

Full Text PDF (128 kb)
292
Dirschedl, P.; Grohmann, R.; Schmidt, L. G.:
Reliability of Adverse Drug Reaction Assessment

Full Text PDF (143 kb)
294
Spieß-Kiefer, C.; Grohmann, R.; Rennig, E.; Rüther, E.; Scherer, J.; Schmidt, L. G.:
Acute Delirious Syndromes due to Psychotropic Drugs

Full Text PDF (127 kb)
296
Wolf, B.; Rüther, E.; Brenner, P.-M.; Poser, W.; Schmidt, L. G.:
Abuse of and Dependence on Stimulants and Anorexigenic Drugs in Psychiatric Inpatients

Full Text PDF (156 kb)
298
Bürke, H.; Grohmann, R.; Rüther, E.:
Psychiatric Outpatient Treatment: Developing Methods of Drug Surveillance

Full Text PDF (118 kb)
300
Grohmann, R.; Dirschedl, P.; Rennig, E.; Scherer, J.; Schmidt, L. G.:
Methodological Problems in Assessment of Adverse Drug Reactions with Drug Combinations

Full Text PDF (147 kb)
304
Bischoff, S.; Bruinink, A.; Krauss, J.; Schaub, M.; Vassout, A.:
In Vivo and in Vitro Characterization of Dopamine Receptors in Hippocampus and their Pharmacological Relevance

Full Text PDF (157 kb)
306
Bischoff, S.; Vassout, A.; Delini-Stula, A.; Waldmeier, P.:
Interactions of Cipazoxapine, Citatepine, Eresepine, and Maroxepine with Central Dopamine (DA) Receptors: Effects on in Vivo (³H)Spiperone Binding, DA Metabolism, and Behavioral Parameters

Full Text PDF (149 kb)
308
Fuchs, V.; Coper, H.:
Kinetic Characteristics of Some Neuronal Receptors After Combined Treatment with Diazepam and Haloperidol

Full Text PDF (138 kb)
310
Heil, Th.; Jänicke, B.:
The Influence of P-Hydroxy-norephedrine on "Drug-taking-behavior" to D-Amphetamine

Full Text PDF (93 kb)
312
Jänicke, B.; Schulze, G.:
Capacity of Thermoregulation in Different Aged Rats: Age as a Factor Modifying Thermoregulation

Full Text PDF (110 kb)
314
Müller, W. E.; Groh, B.; Bub, O.; Hofmann, H. P.; Kreiskott, H.:
In vitro and In vivo Studies of the Mechanism of Action of Arfendazam, a novel 1,5-Benzodiazepine

Full Text PDF (154 kb)
316
Waldmeier, P. C.; Bischoff, S.; Bittiger, H.; Hauser, K.; Vassout, A.; Delini-Stula, A.; Haeusler, A.; Schenkel, L.; Storni, A.:
Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine

Full Text PDF (139 kb)
318
Waldmeier, P. C.; Baumann, P. A.:
Ifoxetine: An Unusual 5-HT Uptake Inhibitor or an Inhibitor of 5-HT Release?

Full Text PDF (129 kb)
322
Spiegel, R.; Berger, M.:
Workshop on Pharmacological and Clinical Studies with Cholinergic Drugs in Humans

Full Text PDF (54 kb)
323
Azcona, A.; Roth, S.; Spiegel, R.:
Effects of the Muscarinic Agonist RS 86 in Healthy Volunteers

Full Text PDF (167 kb)
326
Berger, M.; Krieg, J. C.; Rummler, R.; Raptis, C.; Morinigo, A.; Dose, M.; Benker, B.:
The Treatment of Mania with the Cholinomimetic Drug RS 86

Full Text PDF (128 kb)
328
Tegeler, J.:
Cholinergic Drugs for the Treatment of Tardive Dyskinesia

Full Text PDF (175 kb)
333
Kallus, K. W.:
Agglutination of Single-case Data: Application to Individual Data in Experimental Designs

Full Text PDF (126 kb)
337
Frank, D. R.:
Psychological Theories of the Effects of Placebos with Special Consideration for the Attribution Theory

Full Text PDF (151 kb)
339
Herz, A.:
The Role of Opioid Peptides in Placebo-induced Effects

Full Text PDF (99 kb)
341
Maier, W.; Buller, R.; Philipp, M.; Frommberger, U.:
Placebo-Controlled Long-Term Studies in Chronic Depressed Patients: Evaluation by Single-Case-Analyses

Full Text PDF (116 kb)
343
Laakmann, G.; Blaschke, D.:
Use of Placebo in Clinical Trials on Therapeutic Efficacy of Newly Developed Drugs in Outpatients

Full Text PDF (141 kb)
345
Janke, W.:
Consistency of Response to Placebo with Different Instructions

Full Text PDF (107 kb)
347
Saupe, R.:
The Use of Placebo as Seen by Nursing Staff

Full Text PDF (115 kb)
Discusion groups
140
Bischoff, S.; Bürki, H. R.; Emrich, H. M.; Jaeckel, J.; Kornhuber, J.; Ruhland, M.; Schmid, W. J.; Woggon, B.:
Biochemical and Molecular Mechanisms of Action of Neuroleptics, Alternatives to the Classical Dopamine Hypothesis: Minutes of the Discussion Group

Full Text PDF (389 kb)
Methodological Problems in Planning, Performing and Analysing of Long-Term Studies with psychotropic Drugs
152
Schou, M.:
Methodological Problems of Prophylactic Trials in Recurrent Affective Illness
A Historical Perspective

Full Text PDF (297 kb)
Methodology of Clinical Trials
170
Haug, H.-J.; Fähndrich, E.:
Problems in Defining Response in Therapy Studies

Full Text PDF (104 kb)
Pharmaco-EEG, Sleep,Neuropsychophysiology
198
Wiegand, M.; Berger, M.; Zulley, J.; von Zerssen, D.:
The Effect of Trimipramine on Sleep in Patients with Major Depressive Disorder

Full Text PDF (147 kb)
Antipsychotic Drugs and Extrapyramidal Side-Effects
204
Woggon, B.; Beckmann, H.; Heinrich, K.; Linden, M.; Krebs, E.; Küfferle, B.; Pflug, B.; Rüther, E.; Schied, H. W.:
Clinically Relevant Differences in the Therapeutic Profile of Fluperlapine Compared to Haloperidol in the Treatment of Schizophrenic Psychosis - Results of a Multicentre Double-blind Study

Full Text PDF (128 kb)
Antipsychotic Drugs:Clinical Studies and Psychophysiology
208
Gaebel, W.; Pietzcker, A.; Baumgartner, A.:
3-Year Follow-up of Schizophrenic Patients - Outcome Dimensions and Neuroleptic Treatment

Full Text PDF (115 kb)
Immunology and Neuroendocrinology in Psychic Disorders
226
Moises, H. W.; Beck, J.; Schindler, L.; Kirchner, H.:
Decreased Interferon Production in Schizophrenic Patients

Full Text PDF (117 kb)
Antidepressant Drugs
243
Oefele, K. v; Grohmann, R.; Rüther, E.:
Adverse Drug Reactions in Combined Tricyclic and MAOI Therapy

Full Text PDF (140 kb)
Lithium
274
Hegerl, U.; Ulrich, G.; Müller-Oerlinghausen, B.:
Augmenting - Reducing Response to Auditory Evoked Potentials and its Relationship to the Prophylactic Effect of Lithium Salts

Full Text PDF (137 kb)
Adverse Drug Reactions(The AMüP Study Group)
288
Schmidt, L. G.; Grohmann, R.; Müller-Oerlinghausen, B.; Ochsenfahrt, H.:
Tolerability and Safety of Antidepressant Drugs in Psychiatric In- and Out-patients Assessed by two Drug Surveillance Systems

Full Text PDF (161 kb)
Experimental Pharmacology
302
Bering, B.; Spira, F.; Schanz, H.; Gattaz, W. F.; Müller, W. E.:
Do Human Erythrocyte Membranes Contain Muscarinic Cholinergic Receptors?

Full Text PDF (137 kb)
Drug Epidemiology
320
Koenig, W.; Rüther, E.; Filipiak, B.; Keil, U.:
Determinants of Psychotropic Drug Intake in a Metropolitan Population

Full Text PDF (142 kb)
Workshop on One Case Experiments in Pharmacopsychiatry - Possibilities and Limitations
331
Wolf, G. K.:
Basic Questions for the Use of Single Case Statistics

Full Text PDF (109 kb)
Workshop on New Aspects of the Placebo Problem
335
Netter, P.; Heck, S.; Müller, H. J.:
What Selection of Patients is Achieved by Requesting Informed Consent in Placebo Controlled Drug Trials?

Full Text PDF (138 kb)

Archive
Free Sample Issue

Journal

About
Editorial Board
German National License
Imprint
Bluesky
Linkedin

Authors

Information for Authors
Submit a Manuscript

Subscription

Subscription Information & Contacts
Institutional Licencing

AGNP

Information for Authors
Submit a Manuscript

Collections

Information for Authors
Submit a Manuscript

You are using the licensed access of Thieme Update

Your contact: Thieme Publishers Marketing

Journals
Book Series
Login
Help
Portal
Return to Classic Website

German English

Thieme E-Books & E-Journals is a service of Georg Thieme Verlag and Thieme Medical Publishers, Inc.
© Georg Thieme Verlag KG

All Rights reserved.

Imprint | Privacy policy statement

Your Current IP Address: 216.73.216.144